Puerperal streptococcal toxic shock syndrome treated with recombinant human activated protein C and intravenous immunoglobulin

被引：7

作者：

Al-Rawi, S. ^{[1
]}

Woodward, L. J. ^{[1
]}

Knight, J. ^{[2
]}

机构：

[1] Southampton Univ Hosp NHS Trust, Shackleton Dept Anaesthesia, Southampton SO16 6YD, Hants, England

[2] N Hampshire Hosp NHS Fdn Trust, Basingstoke, Hants, England

来源：

INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA | 2009年 / 18卷 / 02期

关键词：

Puerperal sepsis; Group A streptococcal infections; Recombinant human activated protein C; Intravenous immunoglobulin; Heparin-induced thrombocytopenia; SEVERE SEPSIS; EFFICACY; PATIENT; ADULT;

D O I：

10.1016/j.ijoa.2008.10.003

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Group A streptococcal sepsis is an uncommon management challenge and has a potentially fulminate course. We present the case of a 25-year-old woman who, within 24 It of spontaneous vaginal delivery at 32 weeks of gestation, developed signs of systemic infection and multi-organ failure requiring admission to the intensive care Unit. Recombinant human activated protein C and intravenous immunoglobulin were used subsequently heparin-induced thrombocytopenia and pulmonary embolus also required treatment. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：169 / 172

页数：4

共 14 条

[1]

[Anonymous], European public assessment report

[2] Severe group A streptococcal infection and streptococcal toxic shock syndrome [J].

Baxter, F ;

McChesney, J .

CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2000, 47 (11) :1129-1140

[3] Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[4] DEFINING THE GROUP-A STREPTOCOCCAL TOXIC SHOCK SYNDROME - RATIONALE AND CONSENSUS DEFINITION [J].

BREIMAN, RF ;

DAVIS, JP ;

FACKLAM, RR ;

GRAY, BM ;

HOGE, CW ;

KAPLAN, EL ;

MORTIMER, EA ;

SCHLIEVERT, PM ;

SCHWARTZ, B ;

STEVENS, DL ;

TODD, JK .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (03) :390-391

[5] THE PROTEIN-C ANTICOAGULANT PATHWAY [J].

ESMON, CT .

ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (02) :135-145

[6] Case mix, outcome and activity for obstetric admissions to adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database [J].

Harrison, David A. ;

Penny, James A. ;

Yentis, Steve M. ;

Fayek, Samia ;

Brady, Anthony R. .

CRITICAL CARE, 2005, 9 (Suppl 3) :S25-S27

[7] Incidence, treatment and outcome of peripartum sepsis [J].

Kankuri, E ;

Kurki, T ;

Carlson, P ;

Hiilesmaa, V .

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (08) :730-735

[8]

Mahabeer N, 2005, HOSP MED, V66, P124

[9] Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation:: A case report [J].

Medve, L ;

Csitári, IK ;

Molnár, Z ;

László, A .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (03) :864-865

[10] Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: Implications for therapeutic efficacy [J].

Norrby-Teglund, A ;

Basma, H ;

Andersson, J ;

McGeer, A ;

Low, DE ;

Koth, M .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) :631-638

← 1 2 →